Genetic and Epigenetic Associations with Pre-Chronic Obstructive Pulmonary Disease Lung Function Trajectories

dc.contributor.authorMartino, David J.
dc.contributor.authorBui, Dinh S.
dc.contributor.authorLi, Shuai
dc.contributor.authorIdrose, Sabrina
dc.contributor.authorPerret, Jennifer
dc.contributor.authorLowe, Adrian J.
dc.contributor.authorLodge, Caroline J.
dc.contributor.authorBowatte, Gayan
dc.contributor.authorMoodley, Yuben
dc.contributor.authorThomas, Paul S.
dc.contributor.authorZosky, Graeme
dc.contributor.authorHansbro, Philip M.
dc.contributor.authorHolloway, John W.
dc.contributor.authorSvanes, Cecilie
dc.contributor.authorFaner, Rosa
dc.contributor.authorWalters, Eugene H.
dc.contributor.authorDharmage, Shyamali C.
dc.date.accessioned2024-02-27T12:27:02Z
dc.date.available2024-02-27T12:27:02Z
dc.date.issued2023-11-15
dc.date.updated2024-02-27T12:27:02Z
dc.description.abstractUnderstanding the molecular mechanisms of lung function trajectories that progress to chronic obstructive pulmonary disease (COPD) (pre-COPD trajectories), especially those with a rapidly declining phenotype, should inform preventive interventions. The Tasmanian Longitudinal Health Study (TAHS) previously defined life-course lung function trajectories by serial spirometry in a cohort of all seven-year-old school children in the state of Tasmania recruited in 1968 and followed up to age 53 years (1). Of the six pre-bronchodilator FEV1 lifetime trajectories identified, three collectively accounted for 75% of chronic obstructive pulmonary disease (COPD) prevalence at age 53 years (2). These high-risk trajectories were: 1) early below average lung function (with usual rate of subsequent decline), 2) persistently low, and 3) early below average lung function with accelerated decline. The TAHS cohort provides a unique opportunity to investigate molecular factors associated with disadvantaged trajectories, and we conducted a pilot study in this cohort to characterize associations with COPD high-risk trajectories to inform more extensive longitudinal studies in the future.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec744451
dc.identifier.idimarina9380576
dc.identifier.issn1073-449X
dc.identifier.urihttps://hdl.handle.net/2445/208126
dc.language.isoeng
dc.publisherAmerican Thoracic Society
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1164/rccm.202306-1025LE
dc.relation.ispartofAmerican Journal of Respiratory and Critical Care Medicine, 2023, vol. 208, num.10, p. 1135-1137
dc.relation.urihttps://doi.org/10.1164/rccm.202306-1025LE
dc.rights(c) American Thoracic Society, 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Biomedicina)
dc.subject.classificationMalalties del pulmó
dc.subject.classificationGenètica
dc.subject.classificationEpigènesi
dc.subject.otherPulmonary diseases
dc.subject.otherGenetics
dc.subject.otherEpigenesis
dc.titleGenetic and Epigenetic Associations with Pre-Chronic Obstructive Pulmonary Disease Lung Function Trajectories
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
847529.pdf
Mida:
294.32 KB
Format:
Adobe Portable Document Format